These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16552181)

  • 1. Focal adhesion kinase signaling and the aggressive melanoma phenotype.
    Hess AR; Hendrix MJ
    Cell Cycle; 2006 Mar; 5(5):478-80. PubMed ID: 16552181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
    Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
    PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics.
    Li S; Dong W; Zong Y; Yin W; Jin G; Hu Q; Huang X; Jiang W; Hua ZC
    Mol Ther; 2007 Mar; 15(3):515-23. PubMed ID: 17285141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase regulates collagen I-induced airway smooth muscle phenotype switching.
    Dekkers BG; Spanjer AI; van der Schuyt RD; Kuik WJ; Zaagsma J; Meurs H
    J Pharmacol Exp Ther; 2013 Jul; 346(1):86-95. PubMed ID: 23591997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma.
    Kahana O; Micksche M; Witz IP; Yron I
    Oncogene; 2002 Jun; 21(25):3969-77. PubMed ID: 12037679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
    Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
    Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells.
    Hamamura K; Tsuji M; Ohkawa Y; Nakashima H; Miyazaki S; Urano T; Yamamoto N; Ueda M; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2008 Mar; 1780(3):513-9. PubMed ID: 18078823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAK regulates E-cadherin expression via p-SrcY416/p-ERK1/2/p-Stat3Y705 and PPARĪ³/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
    Pei G; Lan Y; Chen D; Ji L; Hua ZC
    Oncotarget; 2017 Feb; 8(8):13898-13908. PubMed ID: 28108732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for focal adhesion kinase in tumor cell adhesion.
    Maung K; Easty DJ; Hill SP; Bennett DC
    Oncogene; 1999 Nov; 18(48):6824-8. PubMed ID: 10597292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes.
    Heidkamp MC; Bayer AL; Kalina JA; Eble DM; Samarel AM
    Circ Res; 2002 Jun; 90(12):1282-9. PubMed ID: 12089066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
    Nihal M; Wood GS
    Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
    Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG
    Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Focal Adhesion Kinase through a Direct Interaction with an Endogenous Inhibitor.
    Zak TJ; Koshman YE; Samarel AM; Robia SL
    Biochemistry; 2017 Sep; 56(35):4722-4731. PubMed ID: 28782937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
    Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
    Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.
    Kornberg LJ
    Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
    Wang HC; Chu YL; Hsieh SC; Sheen LY
    Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of motile and invasive cell phenotypes by focal adhesion kinase.
    Schlaepfer DD; Mitra SK; Ilic D
    Biochim Biophys Acta; 2004 Jul; 1692(2-3):77-102. PubMed ID: 15246681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells.
    Haskell H; Natarajan M; Hecker TP; Ding Q; Stewart J; Grammer JR; Gladson CL
    Clin Cancer Res; 2003 Jun; 9(6):2157-65. PubMed ID: 12796381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.